Erick Lucera - 17 May 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role: EVP, CHIEF FINANCIAL OFFICER
Signature: /s/ Erick Lucera
Issuer symbol: EDIT
Transactions as of: 17 May 2023
Net transactions value: $0
Form type: 4
Filing time: 18 May 2023, 17:20:05 UTC
Previous filing: 05 Apr 2023
Next filing: 20 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDIT	Common Stock	Award	$0	+77,900		$0.000000	77,900	17 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDIT	Stock Option (right to buy)	Award	$0	+155,800		$0.000000	155,800	17 May 2023	Common Stock	155,800	$9.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on May 17, 2024 continuing through May 17, 2027.
F2	This option was granted on May 17, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on May 17, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through May 17, 2027.